Concurrent Sulforaphane and Eugenol Induces Differential Effects on Human Cervical Cancer Cells
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background. The concept of combination of chemoprevention holds great potential for cancer management as lower, clinically tolerable doses of individual agents could be achieved through therapeutic synergy. However, elucidation of their possible interactions—additive, synergistic, or antagonistic—must be thoroughly studied before considering for clinical use. Methods. To evaluate the effect of combination treatment of sulforaphane (SFN) and eugenol on HeLa cells, the authors performed cell viability assay, apoptosis assay, and reverse transcription polymerase chain reaction for gene expression analysis. Calculations of combination effects were expressed as a combination index (CI) with CI < 1, CI = 1, or CI > 1 representing synergism, additivity, or antagonism, respectively. Results. Simultaneous treatment with variable dose combinations of SFN and eugenol resulted in differential effects with an antagonistic effect at lower and synergistic at higher sub-lethal doses as reflected in cell cytotoxicity and apoptosis induction. Importantly, gemcitabine used in conjunction with the low- and high-dose combinations showed no significant cell death at lower doses suggesting that cell cytotoxicity is proportional to gemcitabine alone, whereas at higher sublethal doses of SFN and eugenol, it was found to act in a synergistic manner with gemcitabine. Furthermore, SFN and eugenol combinations at synergistic dose significantly downregulated the expression of Bcl-2, COX-2 and IL-β but not the antagonistic combinations. Conclusion. This study clearly indicates that 2 (or more) chemopreventive agents can act antagonistically or synergistically necessitating elucidation of possible mechanistic interactions for favorable and reliable outcomes of dietary components in the field of cancer prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Cited by
Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives
Khalil, A. A., Rahman, U. U., Khan, M. R., Sahar, A., Mehmood, T., & Khan, M. (2017) · RSC Advances · doi:10.1039/c7ra04803c · Cited by 407
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Yarla, N. S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A. M., Dhananjaya, B. L., Dowluru, K. S. V. G. K., Chintala, R., & Duddukuri, G. R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.001 · Cited by 364
Pezzani, R., Salehi, B., Vitalini, S., Iriti, M., Zuñiga, F., Sharifi-Rad, J., Martorell, M., & Martins, N. (2019) · Medicina · doi:10.3390/medicina55040110 · Cited by 264
Lesgards, J., Baldovini, N., Vidal, N., & Pietri, S. (2014) · Phytotherapy Research · doi:10.1002/ptr.5165 · Cited by 156
Kamal, M. M., Akter, S., Lin, C.-N., & Nazzal, S. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01225-2 · Cited by 115
Metadata
- Authors
- Hussain, A., Priyani, A., Sadrieh, L., Brahmbhatt, K., Ahmed, M., & Sharma, C.
- Venue
- Integrative Cancer Therapies
- Publisher
- SAGE Publications
- Published
- 2011-03-07
- Volume
- 11
- Issue
- 2
- Pages
- 154-165
- ISSN
- 1534-7354 (ISSN-L)
- 1552-695X
- OpenAlex
- W2012897761
- Cited by
- 52
- References
- 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Concurrent Sulforaphane and Eugenol Induces Differential Effects on Human Cervical Cancer Cells. https://app.cochat.ai/papers/10.1177/1534735411400313
- The paper
- Hussain, A., Priyani, A., Sadrieh, L., Brahmbhatt, K., Ahmed, M., & Sharma, C. (2012). Concurrent Sulforaphane and Eugenol Induces Differential Effects on Human Cervical Cancer Cells. Integrative Cancer Therapies. https://doi.org/10.1177/1534735411400313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.